Electromed, Inc. 10-Q

Item 5. Other Information. During the three months ended September 30, 2024, no director or officer of the Company adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K. 17 Item 6. Exhibits. Exhibit Number Description Method of Filing 3.1 Composite Articles of Incorporation, as amended through November 8, 2010 (incorporated by reference to Exhibit 3.1 to Annual Report on Form 10-K for the fiscal year ended June 30, 2015) Incorporated by Reference 3.2 Amended and Restated Bylaws, effective September 29, 2020 (incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed September 29, 2020) Incorporated by Reference 10.1 Form of Non-Qualified Stock Option Agreement under the 2023 Equity Incentive Plan* Filed Electronically 10.2 Form of Restricted Stock Agreement (Employees) under the 2023 Equity Incentive Plan* Filed Electronically 31.1 Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Filed Electronically 31.2 Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Filed Electronically 32.1 Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Furnished Electronically 32.2 Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Furnished Electronically 101 Financial statements from the Quarterly Report on Form 10-Q for the period ended September 30, 2024, formatted in inline XBRL: (i) Condensed Balance Sheets, (ii) Condensed Statements of Operations, (iii) Condensed Statements of Cash Flows, (iv) Condensed Statements of Shareholders’ Equity, (v) Notes to Condensed Financial Statements, and (vi) the information set forth in Part II, Item 5 Filed Electronically 104 Cover Page Interactive Data File (embedded within the inline XBRL Document) Filed Electronically *Management compensatory contract or arrangement. 18 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ELECTROMED, INC. Date: November 12, 2024 /s/ James L. Cunniff James L. Cunniff, President and Chief Executive Officer (duly authorized officer) Date: November 12, 2024 /s/ Bradley M. Nagel Bradley M. Nagel, Chief Financial Officer (principal financial officer and principal accounting officer)